deCODE genetics (Nasdaq:DCGN) today
announced that CEO Kari Stefansson will present at BioCentury's 13th
annual Future Leaders in the Biotech Industry conference on Thursday,
March 30. The presentation will be delivered at 4:00pm EST/9:00 pm GMT
at the Millennium Broadway hotel in New York and will be webcast live.
The webcast can be accessed through the Investors page on deCODE's website, www.decode.com.
Those interested in listening should log on a few minutes in advance in
order to download any software or complete any sign-in that may be
required.
About deCODE
deCODE genetics (Nasdaq:DCGN) is a
biopharmaceutical company applying its discoveries in human genetics to
the development of drugs for common diseases. deCODE is a global leader
in gene discovery - our population approach and resources have enabled
us to isolate key genes contributing to major public health challenges
from cardiovascular disease to cancer, genes that are providing us with
drug targets rooted in the basic biology of disease. deCODE is also
leveraging its expertise in human genetics and integrated drug
discovery and development capabilities to offer innovative products and
services in DNA-based diagnostics, bioinformatics, genotyping,
structural biology, drug discovery and clinical development. deCODE is
delivering on the promise of the new genetics.SM Visit us on the web at
www.decode.com.
